Article
A robust in vivo model for B cell precursor acute lymphoblastic leukemia.
The Journal of clinical investigation - 1 Sept 2015
Fry Terry J, Aplan Peter D
Abstract excerpt
B cell precursor acute lymphoblastic leukemia (BCP ALL) is the most common malignancy in children. While treatments have improved remarkably over the past four decades, resistant disease and late effects that result from cytotoxic chemotherapy remain serious problems for individuals with BCP ALL. Improved genetic tools have led to the discovery of numerous somatic mutations associated with BCP ALL, leading to a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
